NCT00681408View on ClinicalTrials.gov

Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Non-alcoholic SteatohepatitisFatty Liver
Interventions
DRUG

Omega 3 Fish Oil supplements

Subjects in this arm will receive 3 grams daily Omega 3 fish oil supplements

DRUG

Placebo

Fish oil placebo pills

Trial Locations (1)

22908

University of Virginia School of Medicine, Charlottesville

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Virginia

OTHER

NCT00681408 - Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter